Lee Hambright Analyst PerformanceAnalyst at Sanford C. BernsteinLee Hambright is a stock analyst at Sanford C. Bernstein focused in the medical sector, covering 12 publicly traded companies. Over the past year, Lee Hambright has issued 23 stock ratings, including buy and hold recommendations. While full access to Lee Hambright's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lee Hambright's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings29 Last 6 YearsBuy Recommendations74.07% 20 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution27RatingsDistribution of strong buy, buy, hold, and sell ratings by Lee Hambright.RatingPercentageCount Strong Buy0.0%0 ratings Buy74.1%20 ratings Hold25.9%7 ratings Sell0.0%0 ratingsOut of 27 total stock ratings issued by Lee Hambright at Sanford C. Bernstein, the majority (74.1%) have been Buy recommendations, followed by 25.9% Hold.Best & Worst CallsBest Call000.0%ISRGJul 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MDTMay 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE58.3% of companies on NYSE7 companiesNASDAQ41.7% of companies on NASDAQ5 companiesLee Hambright, an analyst at Sanford C. Bernstein, currently covers 12 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical11 companies91.7%Manufacturing1 company8.3%Lee Hambright of Sanford C. Bernstein specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED PRODUCTS6 companies50.0%MED INSTRUMENTS4 companies33.3%LARGE CAP PHARMA1 company8.3%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company8.3% Lee Hambright's Ratings History at Sanford C. Bernstein Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPODDInsulet2/19/2026Lower Price Target$258.07$330.00Outperform$0.0000.00% ROIBSXBoston Scientific2/6/2026Reiterated Rating$78.03$112.00Outperform$0.0000.00% ROIISRGIntuitive Surgical1/23/2026Boost Price Target$525.81$750.00Outperform$0.0000.00% ROIJNJJohnson & Johnson1/23/2026Boost Price Target$219.35$225.00Market Perform$0.0000.00% ROIABTAbbott Laboratories1/23/2026Lower Price Target$108.98$125.00Outperform$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$49.00Outperform$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.72$49.00Outperform$0.0000.00% ROIZBHZimmer Biomet1/9/2026Boost Price Target$94.07$99.00Market Perform$0.0000.00% ROITNDMTandem Diabetes Care1/9/2026Reiterated Rating$22.50$25.00Market Perform$0.0000.00% ROISYKStryker1/9/2026Boost Price Target$367.13$465.00Outperform$0.0000.00% ROIPODDInsulet1/9/2026Lower Price Target$292.89$380.00Outperform$0.0000.00% ROIMDTMedtronic1/9/2026Boost Price Target$98.78$112.00Outperform$0.0000.00% ROIJNJJohnson & Johnson1/9/2026Boost Price Target$205.78$208.00Market Perform$0.0000.00% ROIISRGIntuitive Surgical1/9/2026Reiterated Rating$585.08$740.00Outperform$0.0000.00% ROIDXCMDexCom1/9/2026Reiterated Rating$68.43$86.00Outperform$0.0000.00% ROIABTAbbott Laboratories1/9/2026Boost Price Target$125.83$154.00Outperform$0.0000.00% ROIMDTMedtronic11/19/2025Set Price Target$100.46$111.00$0.0000.00% ROIEWEdwards Lifesciences11/3/2025Reiterated Rating$82.48$90.00Market Perform$0.0000.00% ROIDXCMDexCom11/3/2025Reiterated Rating$58.22$84.00Outperform$0.0000.00% ROIMDTMedtronic10/31/2025Reiterated Rating$91.06$98.00Outperform$0.0000.00% ROIISRGIntuitive Surgical10/21/2025Reiterated Rating$463.17$685.00Outperform$0.0000.00% ROIJNJJohnson & Johnson10/6/2025Boost Price Target$188.51$193.00Market Perform$0.0000.00% ROIMDTMedtronic8/20/2025Boost Price Target$89.92$98.00Outperform$0.0000.00% ROISYKStryker5/5/2025Set Price Target$383.84$450.00$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
